advertisement
Ianchulev T 17
Showing records 1 to 17 | Display all abstracts from Ianchulev T79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Pasquale LR
Clinical Ophthalmology 2018; 12: 2451-2457
79872 Supraciliary microstent implantation for open-angle glaucoma: multicentre 3-year outcomes
Grisanti S
BMJ open ophthalmology 2018; 3: e000183
80055 Corneal Endothelial Cell Density and Morphology After Phacoemulsification in Patients With Primary Open-Angle Glaucoma and Cataracts: 2-Year Results of a Randomized Multicenter Trial
Ianchulev T
Cornea 2019; 38: 325-331
79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Lin S
Clinical Ophthalmology 2018; 12: 2451-2457
80055 Corneal Endothelial Cell Density and Morphology After Phacoemulsification in Patients With Primary Open-Angle Glaucoma and Cataracts: 2-Year Results of a Randomized Multicenter Trial
Lane S; Masis M
Cornea 2019; 38: 325-331
79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Weinreb RN
Clinical Ophthalmology 2018; 12: 2451-2457
79872 Supraciliary microstent implantation for open-angle glaucoma: multicentre 3-year outcomes
García-Feijoó J
BMJ open ophthalmology 2018; 3: e000183
80055 Corneal Endothelial Cell Density and Morphology After Phacoemulsification in Patients With Primary Open-Angle Glaucoma and Cataracts: 2-Year Results of a Randomized Multicenter Trial
Lass JH
Cornea 2019; 38: 325-331
79872 Supraciliary microstent implantation for open-angle glaucoma: multicentre 3-year outcomes
Dick HB
BMJ open ophthalmology 2018; 3: e000183
79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Tsai JC
Clinical Ophthalmology 2018; 12: 2451-2457
80055 Corneal Endothelial Cell Density and Morphology After Phacoemulsification in Patients With Primary Open-Angle Glaucoma and Cataracts: 2-Year Results of a Randomized Multicenter Trial
Benetz BA
Cornea 2019; 38: 325-331
79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Kramm RL
Clinical Ophthalmology 2018; 12: 2451-2457
79872 Supraciliary microstent implantation for open-angle glaucoma: multicentre 3-year outcomes
Muñoz-Negrete FJ; Arrondo E
BMJ open ophthalmology 2018; 3: e000183
79689 Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose
Ianchulev T
Clinical Ophthalmology 2018; 12: 2451-2457
80055 Corneal Endothelial Cell Density and Morphology After Phacoemulsification in Patients With Primary Open-Angle Glaucoma and Cataracts: 2-Year Results of a Randomized Multicenter Trial
Menegay HJ
Cornea 2019; 38: 325-331
79872 Supraciliary microstent implantation for open-angle glaucoma: multicentre 3-year outcomes
Ianchulev T
BMJ open ophthalmology 2018; 3: e000183
80055 Corneal Endothelial Cell Density and Morphology After Phacoemulsification in Patients With Primary Open-Angle Glaucoma and Cataracts: 2-Year Results of a Randomized Multicenter Trial
Price FW; Lin S
Cornea 2019; 38: 325-331
